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Introduction
Remarkable progress in our understanding of the genetic, molecular, and pathogenic 
mechanisms underlying congenital structural or functional brain defects has 
paralleled progress in developmental and molecular neurobiology. The extraordinary 
information about the sequence of molecular and structural events controlling brain 
development, and likewise, the effects of gene dysregulation in the pathogenesis of 
many well-recognized but poorly understood malformations, continues to emerge 
at an exciting pace. Three of the most important contributions that have advanced 
this knowledge are the capability to perform detailed neuroimaging in patients with 
MRI, the draft of the human genome sequence, and the ability to perform high-
density genomic testing in patients and families. Imaging has provided more refined 
correlations between clinical symptomatology, progression of disease, while the 
genomic evaluations has fueled the identification of the causes of these diseases, 
which has resulted in improved diagnosis, increased prognostic information, and in 
some cases, led to the development of clinical trials of new treatments.
Normal embryonic development
Knowledge of nervous system embryology is essential for understanding 
developmental abnormalities (Table 1). Nervous system development begins with 
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induction of the neural plate, which then undergoes a 
morphological change toward the neural tube. Failure 
of neural tube closure anywhere along the neural axis 
gives rise to several disorders, including spina bifida and 
anencephaly, and may underlie other conditions such 
as encephaloceles and schizencephaly. Next, the neural 
tube is divided into three major axes: rostal-caudal, 
dorsal-ventral, and medial-lateral. One of the examples 
of a disease that represents failed axis formation is 
holoprosencephaly, in which the dorsal cleft fails to form 
and as a result there is failure to divide the brain into the 
two distinct hemispheres. Next, previously unspecified 
nervous system tissue is endowed with certain 
anatomical and cell-type specific identities. This process 
is termed segmentation or specification; for instance, 
the base of the forebrain is specified to hypothalamic 
tissue. Examples of diseases of this class are septo-optic 
dysplasia and agenesis of the corpus callosum. Next, 
neural stem cells located along the lining of the ventricle 
undergo cell division to produce neurons that populate 
brain structures. The prime example of a disease of this 
class is microcephaly. Next, neurons initiate migration 
from the site birth to towards the developing gray matter 
in a process termed neuronal migration. Next is the 
development of the cerebellum, using some of the same 
mechanisms involved in development of the cerebral 
cortex. The major disorders of cerebellar development 
are Dandy-Walker malformation and Joubert syndrome. 
For the purposes of this review, we will focus on recent 
advances in two of these conditions: Microcephaly and 
Joubert syndrome.
Primary Microcephaly: A disorder of neuronal 
proliferation
Microcephaly is usually defined as an occipitofrontal 
circumference (OFC) that is < 2 SD below the mean 
for patient’s age and gender (1). When congenital 
microcephaly is the only abnormality, then the disorder has 
been designated primary microcephaly or microcephaly 
vera, and is divided into boarderline microcephaly for 
those –2 to –3 SD or severe microcephaly for those 
below –3 SC. The clinical manifestations associated 
with microcephaly are very heterogeneous. In general, 
below-average intelligence is the major finding. 
Although intellectual impairment is seen in only about 
11% of patients with borderline microcephaly, it is seen 
in over 50% of patients with severe microcephaly (2). 
In most patients with severe primary microcephaly, brain 
imaging reveals characteristic abnormalities, designated 
“microcephaly with simplified gyral pattern” (3). At its 
most severe, the gyral pattern becomes so simplified as to 
appear lissencephalic (i.e. lacking gyri and sulci in some 
places), which is designated “microlissencephaly” (3). 
Common associated abnormalities include hypoplastic 
frontal lobes, thin corpus callosum and mild hypoplasia 
of the brainstem and cerebellum. 
Primary microcephaly is divided into two clinical groups. 
The first group is composed of children with severe 
microcephaly but only moderate neurological problems, 
usually with only mild to moderate mental retardation 
without spasticity or epilepsy. The second group is 
composed of children that additionally display adverse 
neurological phenotypes including severe spasticity and 
epilepsy. These children have abnormal neonatal reflexes, 
Table 1. Simplified scheme of brain development in humans.
Critical Event in Brain Development
Developmental Window 
(Week of Gestation)
Example of Major Human Diseases
Neural tube closure 3-6 weeks Schizencephaly, Spina bifida
Dorsal cleft formation 5-6 weeks Holoprosencephaly
Ventral specification 5-6 weeks Septo-optic dysplasia, Agen CC
Neuronal proliferation 8-16 weeks (majority) Microcephaly
Neuronal migration movement 10-20 weeks Lissencephaly
Cerebellar development 20-40 weeks and beyond Dandy-Walker, Joubert Sx
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poor feeding, recurrent vomiting and failure-to-thrive (4). 
Additional abnormal MRI findings may be present in this 
second group to include ventriculomegaly, white matter 
signal changes or thickened cortical mantle. Because the 
prognosis is so dramatically different between these two 
phenotypes, it is important to distinguish these as early 
as possible using careful assessment as well as genetic 
evaluations when beneficial.
One of the most exciting recent developments is the 
delineation of Seckle syndrome and microcephalic 
osteodysplastic primordial dwarfism, unique conditions 
characterized by dwarfism, microcephaly, retardation 
and seizures (5). In Seckel syndrome, there is severe 
microcephaly akin to that seen in primary microcephaly, 
but in addition the body of the patients is comparably 
reduced in size. This suggests that there is a class of 
disease that particularly affects brain size, and another 
disease that affects both brain and body size. Thus it is 
important to assess height and weight percentiles when 
evaluating a child with microcephaly, to distinguish 
between primary microcephaly and Seckel syndrome.
Six distinct genetic loci for primary micocephaly have 
been identified (MCPH1-6) with the genes MCPH1, 
CDK5RAP2, ASPM, and CENPJ causing MCPH1, 3, 5, 
and 6 respectively (Table 2) (6). These proteins encoded 
by these critical genes play roles in regulating cell cycle 
and in DNA damage response signaling. The two genes 
for Seckel syndrome to be cloned so far ATR and PCTN, 
encode proteins that also function in cell cycle arrest 
and DNA damage repair in response to DNA damage 
(7,8). Thus it appears that many of the microcephaly 
conditions are probably due to cell cycle regulation in 
regards to perturbed DNA damage response and in the 
regulation of mitotic entry. 
Joubert syndrome: Commonest inherited 
congenital cerebellar ataxia
Human congenital ataxias comprise a group of conditions 
that present in the first few years of life with motor 
disability, muscular hypotonia and incoordination, and 
impaired development. Characteristically, such patients 
display some degree of cerebellar dysplasia that typically 
involves the vermis, and which may accompany other 
developmental brain abnormalities and other non-CNS 
developmental abnormalities. 
Cerebellar hypoplasia may be encountered in several 
different conditions, but additional brain malformations 
or systemic features may help to differentiate these 
various conditions. One of the most helpfuls signs is the 
“molar tooth malformation” (MTM) of the midbrain-
hindbrain junction, which is apparent on axial brain 
MRI section just above the pons. The MTM is a specific 
malformation of the brainstem, cerebellum and the 
cerebellar peduncles, which gives the appearance of a 
tooth-like shape in axial MRI images (9). The appearance 
of the MTM is a result of (1) cerebellar vermis hypoplasia 
that produces enlargement of the IV ventricle; (2) a 
deep interpeduncular fossa and; (3) upwardly rotated 
and elongated superior cerebellar peduncle. The MTM 
is pathognomonic for Joubert syndrome and related 
disorders (JSRD), and its presence can differentiate 
Table 2. Genetic basis of primary microcephaly syndromes involved in DNA damage response.
Condition Clinical features Gene Proposed function
MCPH1 Primary microcephaly MCPH1 DNA damage response and cell ccle regulation
MCPH2 Primary microcephaly unknown
MCPH3 Primary microcephaly CDK5RAP2 Centrosome organization in neurons
MCPH4 Primary microcephaly unknown
MCPH5 Primary microcephaly ASPM Spindle microtubule nucleation at centrosome
Seckel1 Primordial dwarfism with microcephaly ATR G2/M checkpoint defect
Seckel2 Primordial dwarfism with microcephaly PCTN ATR-dependent checkpoint signaling
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JSRD from other cerebellar disorders such as Dandy-
Walker malformation, pontocerebellar hypoplasia and 
isolated vermis hypoplasia (Fig. 2).
Joubert syndrome is a recessively inherited condition that 
is characterized clinically by congenital ataxia, hypotonia, 
episodic breathing dysregulation, and mental retardation 
(10). The signature feature of this disease is the “molar 
tooth” sign. It has been recognized that many patients with 
Joubert syndrome identified by brain imaging studies, 
also display retinal dystrophy and nephronophthisis 
(renal fibrocystic disease) (11), two conditions that are 
proposed to relate to defective function of primary cilia, 
cellular appendages of unclear function, Several recent 
proteomics and bioinformatics studies have identified 
lists of candidate ciliafunctioning proteins, together with 
availability of large, consanguineous families segregating 
the condition, has sped the discovery of several of the 
responsible genes.
Currently, there are seven genetic loci that have 
been mapped for the various subtypes of Joubert 
syndrome, and the first five genes have been identified. 
These include Ableson-helper integration-1 (AHI1), 
Nephrocystin-1 (NPHP1), Centrosomal protein-290 
(CEP290), Transmembrane protein 67 (TMEM67) 
and Retinitis pigmentosa GTPase regulator-interacting 
protein-like (RPGRIP1L). Each of the genes encodes 
a modular scaffolding protein without clear enzymatic 
domains, but sharing several protein-interaction domains 
of unknown function, suggesting that they may be part 
of a signaling complex (12-20). The next few years 
should see the elucidation of the molecular pathways 
regulating cerebellar development, and hopefully some 
of these ideas can be translated into new therapies for 
these patients.
Figure 1. Subtypes of severe congenital microcephaly.  Top row is from a patient with primary microcephaly and simplified gyral 
pattern. Bottom row is from a separate patient with primary microcephaly with markedly enlarged extra-axial spaces and lateral 
ventricles, also with white-matter changes and cerebellar hypoplasia.  The patient at bottom display severe spasticity and intractable 
epilepsy.  Adopted from [21] with permission.
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Future prospects
In the field of child neurology, one of the main ways that 
we can help improve knowledge of the conditions that 
we treat is to help uncover the cause of disease through 
collaborative research study. In the field of genetics, this 
takes the form of helping to identify new genetic forms 
of disease and aiding to identify the genetic cause of 
disease. Gene mutations underlie a majority of the cases 
that we treat in our clinics, and it is the astute clinician 
that can recognize when a particular patient or family 
can help advance research in the field.
For recessive diseases, one of the main ways to help 
advance knowledge is by identifying families that can be 
used for gene evaluation. For example, our Neurogenetics 
Laboratory at the University of California is working to 
identify the genetic causes of recessive disease in Iran 
and the Middle East using a gene mapping strategy. In 
this approach, we work to identify large families with 
documented consanguinity in which there are several 
children displaying the same disease. The parents in 
such an ideal family are typically related to one another 
through cousin marriage, or are from the same small 
town. Also, it is ideal if cousins with the same disorder 
are identified as well, which helps to increase the 
likelihood of finding a diseased chromosomal interval. 
It is key to have such ideal, albeit rare, families invited 
Figure 2. Spectrum of human cerebellar malformations.  Top row: Axial at the level of the midbrain-hindbrain junction (isthmus). 
Bottom row: Midline sagittal. In normal, ishmus shape is relatively circular, and cerebellar vermis is full.  In all of the conditions 
except rhombencephalosynapsis the cerebellar vermis is hypoplastic (double arrows on bottom row).  In Joubert syndrome the 
isthmus takes the shape of a “molar tooth” (arrows). In Dandy-Walker malformation, the posterior fossa is full of fluid (white field) 
and bottom shows the cystic dilatation of the fourth ventricle (*), which is rotated anteriorly.  In Pontocerebellar hypoplasia the 
brainstem is also involved.  Note small isthmus and vermis (arrow, top) and reduced brainstem volume (arrow, bottom).  Cerebellar 
vermis is hypoplasia shows reduced vermis without other associated features.  Rhombencephalosynapsis shows fusion of the two 
cerebellar hemispheres, and the vermis is replaced by this fusion.  (double arrows, top).
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to participate in research studies that can help uncover 
new causes of disease. The information from the study 
can be helpful to the family, because of identification of 
carriers in the family as well as the mutation that causes 
the disease, which can impact diagnosis and prognosis.
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